Plasma Diaphanous Related Formin 1 Levels Are Associated with Altered Glucose Metabolism and Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Case Control Study

• Published in: Mediators of inflammation Vol. 2022; pp. 1 - 16
• Main Authors: Li, Xing, Liao, Mingyu, Shao, Jiaqing, Li, Weixin, Shi, Liu, Wang, Dong, Ni, Juan, Shen, Qiuyue, Yang, Fan, Peng, Guiliang, Zhou, Ling, Zhang, Yuling, Sun, Zheng, Zheng, Hongting, Long, Min
• Format: Journal Article
• Language: English
• Published: United States Hindawi 2022; John Wiley & Sons, Inc; Wiley
• Subjects: Acne; Age; Amenorrhea; Androgens; Beta cells; Blood glucose; Blood pressure; Body fat; Body Mass Index; Body weight; Case-Control Studies; Cholesterol; Clinical trials; Diabetes; Diabetes mellitus; Female; Follicle-stimulating hormone; Formins; Glucose; Glucose metabolism; Glycosylation; Homeostasis; Hormones; Humans; Insulin; Insulin resistance; Insulin Resistance - physiology; Lipid metabolism; Luteinizing Hormone; Menstruation; Metabolism; Nomograms; Obesity; Ovaries; Overweight; Ovulation; Patients; Plasma; Polycystic Ovary Syndrome; Risk factors; Sex hormones; Signal transduction; Statistical analysis; Testosterone; Tumor necrosis factor-TNF; Womens health; China
• ISSN: 0962-9351; 1466-1861; 1466-1861
• DOI: 10.1155/2022/9620423

Background. Diaphanous related formin 1 (DIAPH1) is a novel component of advanced glycation end product (AGE) signal transduction that was recently found to participate in diabetes-related disorders, obesity, and androgen hormones. We investigated whether plasma DIAPH1 levels were a potential prognostic predictor for polycystic ovary syndrome (PCOS). Methods. The levels of circulating plasma DIAPH1 and indicators of glucose, insulin, lipid metabolism, liver enzymes, kidney function, sex hormones, and inflammation were measured in 75 patients with PCOS and 77 healthy participants. All of the participants were divided into normal-weight (NW) and overweight/obese (OW) subgroups. Statistical analyses were performed with R studio. Results. PCOS patients manifested hyperandrogenism, increased luteinizing hormone/follicle-stimulating hormone (LH/FSH), and accumulated body fat and insulin resistance. Plasma DIAPH1 levels were significantly decreased in women with PCOS compared to control participants, and DIAPH1 levels were distinctly reduced in OW PCOS compared to OW control subjects (P<0.001). DIAPH1 levels correlated with fasting blood glucose (FBG), total cholesterol (TC), the homeostasis model assessment of β-cell function (HOMA-β), and LH/FSH in all participants (FBG: r=0.351, P<0.0001; TC: r=0.178, P=0.029; HOMA-β: r=−0.211, P=0.009; LH/FSH: r=−0.172, P=0.040). Multivariate logistic regression analysis revealed that plasma DIAPH1 levels were an independent risk factor for PCOS. A model containing DIAPH1, BMI, FBG, and testosterone was constructed to predict the risk of PCOS, with a sensitivity of 92.0% and a specificity of 80.9%. A nomogram was constructed to facilitate clinical diagnosis. Conclusions. These findings suggest the association of plasma DIAPH1 with glucose metabolism, insulin resistance, and sex hormones and support DIAPH1 as a potential predictive factor for PCOS.